The guidelines also said Remdesivir (an emergency use authorization drug) is not recommended in children.
There is lack of sufficient safety and efficacy data with respect to Remdesivir in children below 18 years of age, the guidelines said.
The guidelines suggested rational use of High-resolution CT (HRCT) for seeing the extent and nature of lung involvement in patients with COVID-19.
However, any additional information gained from HRCT scan of the chest often has little impact on treatment decisions, which are based almost entirely on clinical severity and physiological impairment. Therefore, treating physicians should be highly selective in ordering HRCT imaging of the chest in COVID-19 patients, the guidelines said.